Extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin, Regulation (EU) 2021/52 of 22 January 2021

Fecha de publicación: 01/03/2021